Abstract:Artificial intelligence (AI) is one of the most rapidly evolving new fields of technology over the past decade. We are now in the era of the fourth industrial revolution, which is characterized by the development of robotics, biotechnology, nanotechnology, the internet of things (IoT), big data, and AI, among others, and we have reached a turning point that includes medical services."These findings indicate that AI technology has now become available to evaluate all the necessary factors for estimating the risk of lymph node metastasis and determining treatment options, with much better accuracy than experts."One key aspect of AI, machine learning, has progressed rapidly because of the technical innovation of deep learning, represented by convolutional neural networks (CNNs). Deep learning is suitable for image recognition and can do this with higher accuracy than humans. Therefore, it is now being increasingly used in daily life, for example for face recognition, self-driving cars, AI chess programs, and so on. It is also very useful in the medical field, especially for radiological image diagnosis, histopathological diagnosis, and endoscopic diagnosis, as these diagnoses are based on pattern recognition by experienced doctors. Among these applications, endoscopic diagnosis seems more challenging than the others because moving images are sometimes used for diagnosis in endoscopy and because endoscope itself is manually controlled by endoscopists, which may affect the quality of images. Despite these difficulties, many studies regarding endoscopic detection and the characterization of gastrointestinal neoplastic lesions have already been published. Among such lesions, gastric cancers present greater challenges for diagnosis owing to the presence of inflammation and undifferentiated-type cancers in the stomach.Gastric cancer is still very common in Eastern Asia. In Japan, in particular, it was a leading cause of cancer death until a few decades ago; consequently, endoscopic techniques for early detection and treatment became highly developed. As a result, the Japanese guidelines for endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) for gastric cancer [<a href="#JR20110-1">1</a>] are now regarded as the global standards for endoscopic treatment. According to these guidelines, it is very important to recognize the differentiation, size, depth, and ulceration findings of the tumor when examining cancerous lesions in the stomach. All these factors are essential for estimating the risk of lymph node metastasis in gastric cancer. Of course, and more importantly, we must detect suspicious lesions during routine esophagogastroduodenoscopy (EGD) while they are still small and flat. Considerable experience is necessary to develop enough skill to detect gastric cancers at an early stage and assess the abovementioned factors. In Japan, images are usually double-checked by an independent expert when EGD is performed as a gastric cancer health checkup. The double-check system is a highly effective way to ensure the quality of the examination and to avoid overlooking cancerous and precancerous lesions, although reviewing a large number of images is usually very tiresome and boring for experts. AI technology is an ideal solution to this problem because endoscopic diagnosis is basically the recognition of a pattern of abnormal mucosa.The use of AI technology for gastric cancer detection was first reported by Hirasawa et al. in 2018 [<a href="#JR20110-2">2</a>]. They used still images of white-light endoscopy, narrow-band imaging (NBI), and chromoendoscopy, and their overall sensitivity was 92.2 %, although the positive predictive value was 30.6 %. This result seemed reasonable for the first reported use of AI technology to detect relatively small and flat early gastric cancers (EGCs). Soon after this publication, they proved the efficacy of this computer-aided diagnosis (CAD) system for the real-time detection of EGCs using video clips [<a href="#JR20110-3">3</a>]. Prof. Yu's group in China also reported the usefulness of AI for the detection of EGCs; however, their unique offering was the ability to monitor blind spots during the procedure [<a href="#JR20110-4">4</a>]. They proved the efficacy of their system for real-time monitoring of blind spots in a randomized control study [<a href="#JR20110-5">5</a>]. This system seemed very effective for improving the quality of EGD screening. Regarding the estimation of the invasion depth of EGCs, another Chinese group has shown the superiority of AI compared with human experts [<a href="#JR20110-6">6</a>]. Additionally, another Japanese group proved the efficacy of AI for this purpose using still images [<a href="#JR20110-7">7</a>]. In addition to these topics, Dr. Ling, a member of Prof. Yu's group, has now addressed the new challenge of evaluating tumor differentia -Abstract Truncated-

Artificial intelligence-based real-time histopathology of gastric cancer using confocal laser endomicroscopy

Analysis of Intraoperative Microscopy Imaging Techniques and Their Future Applications

An artificial intelligence system for comprehensive pathologic outcome prediction in early gastric cancer through endoscopic image analysis (with video)

Artificial Intelligence in the Pathology of Gastric Cancer

Artificial Intelligence-Based Diagnosis of Gastric Mesenchymal Tumors Using Digital Endosonography Image Analysis

Multi-Scale Hybrid Vision Transformer for Learning Gastric Histology: AI-Based Decision Support System for Gastric Cancer Treatment

Abstract 7400: AI-driven multimodal 3D tumor modeling with spatial molecular insights for predicting ICI response in gastric cancer

The Role of Artificial Intelligence in Gastric Cancer: Surgical and Therapeutic Perspectives: A Comprehensive Review

Artificial Intelligence in Gastric Cancer Imaging With Emphasis on Diagnostic Imaging and Body Morphometry

Artificial intelligence for gastric cancer in endoscopy: From diagnostic reasoning to market

A promising deep learning-assistive algorithm for histopathological screening of colorectal cancer

Revealing 3D cancer tissue structures using holotomography and virtual hematoxylin and eosin staining via deep learning

Real-World Application of Artificial Intelligence for Detecting Pathologic Gastric Atypia and Neoplastic Lesions

An artificial intelligence system for chronic atrophic gastritis diagnosis and risk stratification under white light endoscopy

Confocal Laser Endomicroscope with Distal MEMS Scanner for Real-Time Histopathology

Artificial Intelligence in the Prediction of Gastrointestinal Stromal Tumors on Endoscopic Ultrasonography Images: Development, Validation and Comparison with Endosonographers

Endomicroscopic AI-driven morphochemical imaging and fs-laser ablation for selective tumor identification and selective tissue removal

Is artificial intelligence ready to replace expert endoscopists?

Application of artificial intelligence-driven endoscopic screening and diagnosis of gastric cancer